USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

TTABVUE. Trademark Trial and Appeal Board Inquiry System

v2.5.0

Summary

Query: Party Name contains all words: IPSEN S.A.
Number of results: 34
Results are in reverse chronological order

Proceeding
Filing Date

Defendant(s),
Property(ies)

Plaintiff(s),
Property(ies)

91287535
10/06/2023

Invivyd, Inc.
Mark: INVIVYD S#:97562625
Mark: INVIVYD S#:97568177

Clementia Pharmaceuticals Inc., Ipsen S.A. and Ipsen Biopharm Ltd.
Mark: ONIVYDE S#:85971097 R#:4874816

97271995
05/15/2023

Ipsen S.A.
Mark: IPSEN S#:97271995

91284390
04/10/2023

Sarepta Therapeutics, Inc.
Mark: EVOMYO S#:97368273

Ipsen Pharma S.A.S.
Mark: EVOSOM S#:97319091

91250766
09/04/2019

Ipsen Pharma S.A.S.
Mark: ACROMUNITY S#:79237547

Helix OpCo, LLC
Mark: HELIX S#:87539101 R#:5846056
Mark: HELIX S#:87573883 R#:5846086

79237547
06/05/2019

IPSEN PHARMA S.A.S.
Mark: ACROMUNITY S#:79237547

Helix OpCo, LLC

87263764
10/25/2018

Ipsen S.A.
Mark: IPSEN S#:87263764

87637560
10/11/2018

IPSEN PHARMA S.A.S.
Mark: AIRGLOW S#:87637560

Ferton Holding S.A.

91231052
11/07/2016

Ipsen Pharma S.A.S.
Mark: FORLAX S#:86851032

Glaxo Group Limited
Mark: FORTAZ S#:73376990 R#:1286762

86851032
06/06/2016

Ipsen Pharma S.A.S.
Mark: FORLAX S#:86851032

Glaxo Group Limited

91223890
09/18/2015

LSI Medience Corporation
S#:86268259

Ipsen S.A.
Mark: IPSEN S#:79002056 R#:3251886

86549047
08/27/2015

INTRANERVE
Mark: INNOVATIVE DIFFERENCE IN PATIENT CARE S#:86549047

Ipsen S.A.

86268259
04/13/2015

LSI Medience Corporation
S#:86268259

Ipsen S.A.

91220338
01/26/2015

Somahlution, LLC
Mark: SOMAHLUTION S#:86248574

Ipsen Pharma S.A.S.
Mark: SOMATULINE S#:74532825 R#:2286865
Mark: SOMATULINE S#:75789007 R#:2524021

91218333
09/15/2014

Case Western Reserve University
Mark: ISENS S#:86100584

Ipsen S.A.
Mark: IPSEN S#:79002058 R#:3245038

91218331
09/15/2014

Case Western Reserve University
Mark: ISENS S#:86100571

Ipsen S.A.
Mark: IPSEN S#:79002058 R#:3245038

86248574
08/25/2014

Somahlution, LLC
Mark: SOMAHLUTION S#:86248574

Ipsen Pharma S.A.S.

86100584
04/15/2014

Case Western Reserve University
Mark: ISENS S#:86100584

Ipsen S.A.
i-Sens, Inc.

86100571
04/15/2014

Case Western Reserve University
Mark: ISENS S#:86100571

Ipsen S.A.
i-Sens, Inc.

91215451
03/18/2015

Sunesis Pharmaceuticals, Inc.
Mark: ONCYTIQ S#:85909908

Ipsen Pharma S.A.S
Mark: ONTELRIQ S#:79129963 R#:4473154

86060212
02/27/2014

Merck Sharp & Dohme Corp.
Mark: ZUTRAVIS S#:86060212

Ipsen Pharma S.A.S.

85909908
10/14/2013

Sunesis Pharmaceuticals, Inc.
Mark: ONCYTIQ S#:85909908

Ipsen Pharma S.A.S

77628372
10/05/2011

IPSEN S.A.
Mark: IPSEN S#:77628372

77628373
09/28/2011

IPSEN S.A.
Mark: IPSEN INNOVATION FOR PATIENT CARE S#:77628373

79080475
03/09/2011

IPSEN PHARMA S.A.S.
Mark: CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIF S#:79080475

Clarient, Inc.

79080474
03/09/2011

IPSEN PHARMA S.A.S.
Mark: CLARINET S#:79080474

Clarient, Inc.